ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,943Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 817

$866K Total Retail Price of All Prescriptions

Rank: 34 out of 817

337 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 337 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

9% of this provider’s 337 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

0% of this provider’s 13,075 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $89 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
METOPROLOL SUCCINATE 622 610 1 26
LEVOTHYROXINE SODIUM 586 535 2 2
FUROSEMIDE 512 509 3 8
LISINOPRIL 488 473 4 3
OMEPRAZOLE 432 408 5 4
ESCITALOPRAM OXALATE 358 349 6 74
NAMENDA 351 339 7 33
SPIRONOLACTONE 304 304 8 80
ATORVASTATIN CALCIUM 282 266 9 9
PREDNISONE 246 215 10 17
SERTRALINE HCL 237 225 11 24
AMLODIPINE BESYLATE 227 199 12 6
DONEPEZIL HCL 211 198 13 20
SIMVASTATIN 208 188 14 1
METFORMIN HCL ER 206 200 15 142
GABAPENTIN 196 171 16 12
PRADAXA 190 190 17 115
HYDROCODONE-ACETAMINOPHEN 169 124 S3 18 7
LEXAPRO 156 156 19 294
EXELON 153 153 20 123
CITALOPRAM HBR 151 147 21 16
ATENOLOL 151 147 21 14
ALLOPURINOL 151 146 21 50
WARFARIN SODIUM 143 142 24 10
CARBIDOPA-LEVODOPA 133 133 25 52
QUETIAPINE FUMARATE 127 127 26 62
LEVETIRACETAM 125 99 27 68
NOVOLIN 70-30 124 124 28 317
METOPROLOL TARTRATE 122 122 29 5
METFORMIN HCL 121 99 30 13
ACARBOSE 120 120 31 367
TRAMADOL HCL 118 116 32 23
MIRTAZAPINE 107 95 33 40
RISPERIDONE 107 95 33 51
DIOVAN 102 102 35 28
XARELTO 97 97 36 338
HYDROCHLOROTHIAZIDE 94 94 37 15
FLUTICASONE PROPIONATE 92 85 38 48
TAMSULOSIN HCL 92 90 38 11
CYMBALTA 90 66 40 75
FINASTERIDE 88 88 41 25
DEXAMETHASONE SODIUM PHOSPHATE 87 44 42 447
DIGOXIN 84 84 43 37
LIPITOR 82 81 44 126
TOPIRAMATE 76 63 45 81
URSODIOL 73 61 46 274
FAMOTIDINE 71 62 47 71
FLUOXETINE HCL 71 55 47 87
LANTUS 70 56 49 64
AMANTADINE 70 70 49 287
CRESTOR 67 67 51 56
PRAVASTATIN SODIUM 67 61 51 19
ADVAIR DISKUS 66 66 53 32
OXYCODONE-ACETAMINOPHEN 66 65 S2 53 46
GLIMEPIRIDE 66 66 53 88
COMBIVENT 65 52 56 235
LOSARTAN POTASSIUM 65 48 56 29
METOLAZONE 64 64 58 220
SINGULAIR 62 48 59 100
NITROFURANTOIN 62 62 59 166
CLOBETASOL PROPIONATE 58 58 61 118
CEFTRIAXONE 57 55 62 490
ALENDRONATE SODIUM 57 56 62 31
LEVOFLOXACIN 56 55 64 224
AZITHROMYCIN 56 49 64 53
TRAZODONE HCL 55 40 66 41
SPIRIVA 53 53 67 35
NOVOLOG 52 29 68 148
LOPERAMIDE 51 51 69 323
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 12, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.